Moxifloxacin, a new chemical drug of class 3.1 applied for production by new Hecheng, has been accepted
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the public information released by the State Food and Drug Administration on July 29, the new 3.1 chemical drug moxifloxacin declared for production by new Hecheng was accepted This application is a raw material drug, and the company obtained the clinical approval document in October last year Moxifloxacin is a broad-spectrum antibacterial drug, which is not easy to produce drug resistance and has a wide range of clinical applications The sales volume of Bayer's original research drug in China in 2012 reached 1.5 billion yuan At present, Nanjing Youke Pharmaceutical Co., Ltd has obtained the first copy of the drug, and dozens of enterprises are applying for it, with fierce competition.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
